Allogeneic grafts are another success factor of the company. With Osteograft, Argon provides products that meet all the criteria of modern augmentative surgery for GTR and GBR applications. The high standard of the management for maximum safety is fulfilled by the cooperation with the German Institute for Cell and Tissue Replacement (DIZG) in Berlin. Osteograft grafts are manufactured by the DIZG from the German donor program and are approved as drugs. Extensive criteria for donor selection, a donor screening that exceeds the EU directive, and a validated sterilization procedure to remove or inactivate viruses, bacteria and fungi form the basis for the greatest possible product confidence among healthcare providers and patients.